Ceribell CBLL
NASDAQ CBLL
$27.40 +0.26 (+0.96%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ceribell (CBLL) Non-Current Deffered Revenue (2023 - 2025)

Updated

Ceribell (CBLL) posted Non-Current Deffered Revenue of $3,000 for Q3 2025, down 90.9% from $33,000 a year earlier and down 57.1% from the prior quarter.

Analysis

Ceribell (CBLL) Non-Current Deffered Revenue (2023 - 2025) Analysis & Trends

At the end of FY2024, Ceribell's Non-Current Deffered Revenue came in at $30,000, down 31.8% from FY2023.

  • In prior years, Ceribell's Non-Current Deffered Revenue was $44,000 in FY2023.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $7,000 (Q2 2025), $12,000 (Q1 2025) and $30,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn -
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn -
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn -
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn -
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn -
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn -
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn -
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn -
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn -
10 Ceribell 1.04 Bn 443.45 Mn 25.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 12,000.00
Dec 31, 2024 30,000.00
Sep 30, 2024 33,000.00
Dec 31, 2023 44,000.00
API Access

Ceribell Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CBLL&period=max&api_key=YOUR_API_KEY